Phio Pharmaceuticals PHIO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.05 | 20 | -15.81 | -2 | -14.37 | 21 |
| 2025Q3 | 2.48 | 10 | -24.00 | -2 | -20.98 | 12 |
| 2025Q2 | 2.35 | 10 | -19.46 | -2 | -17.51 | 11 |
| 2025Q1 | 1.30 | 12 | -20.94 | -2 | -18.45 | 13 |
| 2024Q4 | 1.80 | 5 | -33.63 | -2 | -28.03 | 6 |
| 2024Q3 | 3.45 | 5 | -34.96 | -2 | -27.31 | 6 |
| 2024Q2 | 6.23 | 4 | -39.37 | -2 | -30.39 | 5 |
| 2024Q1 | 6.12 | 6 | -32.31 | -2 | -26.56 | 7 |
| 2023Q4 | 6.84 | 8 | -25.36 | -2 | -20.05 | 9 |
| 2023Q3 | 13.59 | 7 | -32.48 | -3 | -25.46 | 10 |
| 2023Q2 | 25.83 | 10 | -29.61 | -3 | -23.17 | 12 |
| 2023Q1 | 50.58 | 7 | -39.69 | -4 | -31.99 | 10 |
| 2022Q4 | 40.18 | 11 | -22.42 | -3 | -19.09 | 13 |
| 2022Q3 | 61.70 | 14 | -23.43 | -4 | -19.90 | 16 |
| 2022Q2 | 75.83 | 17 | -13.89 | -3 | -11.97 | 20 |
| 2022Q1 | 95.80 | 19 | -12.77 | -3 | -11.16 | 22 |
| 2021Q4 | 108.00 | 22 | -14.63 | -3 | -12.99 | 25 |
| 2021Q3 | 219.24 | 25 | -13.84 | -4 | -12.56 | 28 |
| 2021Q2 | 244.08 | 29 | -8.92 | -3 | -8.20 | 32 |
| 2021Q1 | 289.44 | 31 | -15.34 | -3 | -13.74 | 34 |